GENEDX ($WGS) posted quarterly earnings results on Wednesday, April 30th. The company reported earnings of $0.28 per share, beating estimates of $0.06 by $0.22. The company also reported revenue of $87,120,000, beating estimates of $80,263,013 by $6,856,987.
You can see Quiver Quantitative's $WGS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GENEDX Insider Trading Activity
GENEDX insiders have traded $WGS stock on the open market 87 times in the past 6 months. Of those trades, 0 have been purchases and 87 have been sales.
Here’s a breakdown of recent trading of $WGS stock by insiders over the last 6 months:
- SCHOOL OF MEDICINE AT MOUNT SINAI ICAHN has made 0 purchases and 3 sales selling 1,012,941 shares for an estimated $75,328,722.
- KATHERINE STUELAND (Chief Executive Officer) has made 0 purchases and 45 sales selling 191,622 shares for an estimated $16,231,205.
- KEVIN FEELEY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 33 sales selling 85,189 shares for an estimated $7,444,309.
- JASON RYAN has made 0 purchases and 6 sales selling 47,000 shares for an estimated $3,316,879.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GENEDX Hedge Fund Activity
We have seen 143 institutional investors add shares of GENEDX stock to their portfolio, and 57 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 669,995 shares (+inf%) to their portfolio in Q4 2024, for an estimated $51,495,815
- LORD, ABBETT & CO. LLC added 630,473 shares (+inf%) to their portfolio in Q4 2024, for an estimated $48,458,154
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC added 582,619 shares (+336.9%) to their portfolio in Q4 2024, for an estimated $44,780,096
- MILLENNIUM MANAGEMENT LLC removed 515,633 shares (-89.8%) from their portfolio in Q4 2024, for an estimated $39,631,552
- BLACKSTONE INC. removed 420,715 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $32,336,154
- MACQUARIE GROUP LTD added 384,480 shares (+inf%) to their portfolio in Q4 2024, for an estimated $29,551,132
- FMR LLC added 348,669 shares (+647.8%) to their portfolio in Q4 2024, for an estimated $26,798,699
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GENEDX Government Contracts
We have seen $45,000 of award payments to $WGS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- GENE DX INC:1108521 [24-002891] GENE DX QUOTE: ZM245 GENE DX INVOICE# Q041924ZM245: $25,000
- GENE DX HEREDITARY MDS/LEUKEMIA PANEL (T830) AND CNV TESTING FOR POTENTIAL PARTICIPANTS WHO DO NOT OTHERWIS...: $20,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
GENEDX Analyst Ratings
Wall Street analysts have issued reports on $WGS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cowen & Co. issued a "Buy" rating on 01/07/2025
To track analyst ratings and price targets for GENEDX, check out Quiver Quantitative's $WGS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
